Study of Radiolabeled ALXN2050 in Healthy Adult Males
NCT04609670
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
[14C]-ALXN2050
Sponsor
Alexion Pharmaceuticals, Inc.